��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title X-linked spinocerebellar ataxia (SCA) type 1A: a novel late onset phenotype of the ATP2B3 mutation

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 392

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Christopher D. Stephen, MB ChB, FRCP, MSc, SM PRESENTER	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
	No disclosure on file
	No disclosure on file
Jeremy D. Schmahmann, MD, FAAN (Massachusettes General Hospital)	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.